Lv11
20 积分 2024-10-25 加入
CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
4小时前
已完结
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
13天前
已完结
Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization
14天前
已完结
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
14天前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
1个月前
已完结
Olverembatinib in chronic myeloid leukemia—Review of historical development, current status, and future research
1个月前
已完结
Olverembatinib: First Approval
1个月前
已完结
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia
1个月前
已完结
An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes
1个月前
已完结
Discovery and preclinical evaluations of drug candidate DA-0157 capable of overcoming EGFR drug-resistant mutation C797S and EGFR/ALK co-mutations
2个月前
已完结
皖公网安备34019202002308
